Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review

The document reports a case of successful treatment of alopecia universalis in a child using upadacitinib, a Janus kinase (JAK) inhibitor. This case highlights the potential of upadacitinib as an effective treatment option for pediatric patients with severe forms of alopecia areata, particularly alopecia universalis. The report is part of a broader literature review that discusses the use of JAK inhibitors in treating alopecia areata and related conditions, emphasizing the growing interest and research in this therapeutic area.